BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

593 related articles for article (PubMed ID: 1535993)

  • 1. [Eosinophilic granulocytes and their significance in allergic diseases].
    Bruijnzeel PL; Rihs S; Betz S
    Schweiz Med Wochenschr; 1992 Feb; 122(6):173-80. PubMed ID: 1535993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating eosinophils in asthma, allergic rhinitis, and atopic dermatitis lack morphological signs of degranulation.
    Malm-Erjefält M; Greiff L; Ankerst J; Andersson M; Wallengren J; Cardell LO; Rak S; Persson CG; Erjefält JS
    Clin Exp Allergy; 2005 Oct; 35(10):1334-40. PubMed ID: 16238793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophil major basic protein induces degranulation and IL-8 production by human eosinophils.
    Kita H; Abu-Ghazaleh RI; Sur S; Gleich GJ
    J Immunol; 1995 May; 154(9):4749-58. PubMed ID: 7722326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eosinophil granule proteins activate human heart mast cells.
    Patella V; de Crescenzo G; Marinò I; Genovese A; Adt M; Gleich GJ; Marone G
    J Immunol; 1996 Aug; 157(3):1219-25. PubMed ID: 8757629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cell activation markers in rhinitis and rhinosinusitis. 1: Eosinophilic cationic protein (ECP)].
    Klimek L; Rasp G
    Laryngorhinootologie; 1996 Nov; 75(11):665-70. PubMed ID: 9063834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of eosinophil cationic protein and eosinophil protein x in pollen atopic patients with stable asthma and its relation with bronchial hyperresponsiveness.
    Chivato T; Martínez D; Blasco R; Melgarejo M; Gómez de Terreros FJ; Laguna R
    Allergol Immunopathol (Madr); 1996; 24(6):243-7. PubMed ID: 9010559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of eosinophilic granulocytes for the pathogenesis of atopic dermatitis /neurodermatitis. Eosinophilic products as markers of disease activity].
    Kapp A
    Hautarzt; 1993 Jul; 44(7):432-6. PubMed ID: 8365876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The roles of adhesion molecules, cytokines, and chemokines in eosinophil activation during allergic inflammation].
    Chihara J
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():116-20. PubMed ID: 9216199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum eosinophil granule proteins predict asthma risk in allergic rhinitis.
    Nielsen LP; Peterson CG; Dahl R
    Allergy; 2009 May; 64(5):733-7. PubMed ID: 19133919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate.
    Woerly G; Decot V; Loiseau S; Loyens M; Chihara J; Ono N; Capron M
    Clin Exp Allergy; 2004 Sep; 34(9):1379-87. PubMed ID: 15347370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The roles of adhesion molecules, cytokines and chemokines in allergic inflammation].
    Chihara J
    Rinsho Byori; 1997 Jun; 45(6):519-27. PubMed ID: 9306709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early activation or "priming" of eosinophils in asthma.
    Bruijnzeel PL; Rihs S; Virchow JC; Warringa RA; Moser R; Walker C
    Schweiz Med Wochenschr; 1992 Feb; 122(9):298-301. PubMed ID: 1546279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral blood eosinophils from patients with allergic asthma contain increased intracellular eosinophil-derived neurotoxin.
    Sedgwick JB; Vrtis RF; Jansen KJ; Kita H; Bartemes K; Busse WW
    J Allergy Clin Immunol; 2004 Sep; 114(3):568-74. PubMed ID: 15356558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro killing of microfilariae of Brugia pahangi and Brugia malayi by eosinophil granule proteins.
    Hamann KJ; Gleich GJ; Checkel JL; Loegering DA; McCall JW; Barker RL
    J Immunol; 1990 Apr; 144(8):3166-73. PubMed ID: 2324497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro diagnosis of chronic nasal inflammation.
    Kramer MF; Burow G; Pfrogner E; Rasp G
    Clin Exp Allergy; 2004 Jul; 34(7):1086-92. PubMed ID: 15248854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between nasal hyperreactivity, mediators and eosinophils in patients with perennial allergic rhinitis and controls.
    de Graaf-in t Veld C; Garrelds IM; Koenders S; Gerth van Wijk R
    Clin Exp Allergy; 1996 Aug; 26(8):903-8. PubMed ID: 8877155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The eosinophilic injury to the mucosa of the airways in the pathogenesis of bronchial asthma.
    Frigas E; Motojima S; Gleich GJ
    Eur Respir J Suppl; 1991 Apr; 13():123s-135s. PubMed ID: 1953909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional CD137 receptors are expressed by eosinophils from patients with IgE-mediated allergic responses but not by eosinophils from patients with non-IgE-mediated eosinophilic disorders.
    Heinisch IV; Bizer C; Volgger W; Simon HU
    J Allergy Clin Immunol; 2001 Jul; 108(1):21-8. PubMed ID: 11447378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge. Characterization of eosinophil and mast cell mediators.
    Sedgwick JB; Calhoun WJ; Gleich GJ; Kita H; Abrams JS; Schwartz LB; Volovitz B; Ben-Yaakov M; Busse WW
    Am Rev Respir Dis; 1991 Dec; 144(6):1274-81. PubMed ID: 1741538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Eosinophils in immediate allergic reactions].
    Takizawa H
    Nihon Rinsho; 1993 Mar; 51(3):664-8. PubMed ID: 8388063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.